文献速递生殖医学

人工卵母细胞激活改善有ICSI受精失败风险的周期:同胞卵母细胞对照研究

Artificial oocyte activation improves cycles with prospects of ICSI fertilization failure: a sibling oocyte control study.
PubMed 文献 · Reprod Biomed Online · 2019-04-05

本研究将既往ICSI受精失败或严重畸形精子症患者的同胞卵母细胞等分为两组,一半在常规ICSI后行离子霉素人工卵母细胞激活(AOA),另一半仅行常规ICSI。AOA组受精率、卵裂率和可移植胚胎率显著优于对照组,但囊胚形成率、种植率、临床妊娠率和活产率无显著差异。

要点

  • AOA组受精率50.38% vs 对照组33.86%,P<0.001。
  • AOA组可移植胚胎率43.51% vs 对照组26.69%,P<0.001。
  • 囊胚形成率、种植率、临床妊娠率及活产率两组无显著差异。

核心结论

  • AOA通过提高受精率和可移植胚胎率改善了有ICSI受精失败风险周期的某些方面,但未改善囊胚形成率、妊娠率和种植率。

研究设计与样本

  • 同胞卵母细胞对照研究,纳入既往ICSI受精失败或严重畸形精子症患者,同胞卵母细胞等分为AOA组(常规ICSI后离子霉素激活)和仅常规ICSI的对照组。

主要发现

  • AOA组受精率50.38% vs 对照组33.86%,P<0.001。
  • AOA组卵裂率59.16% vs 对照组39.04%,P<0.001。
  • AOA组可移植胚胎率43.51% vs 对照组26.69%,P<0.001。
  • 囊胚形成率AOA组43.53% vs 对照组36.11%,无显著差异。
  • 种植率AOA组26.83% vs 对照组15.79%、临床妊娠率38.46% vs 25%、活产率38.46% vs 16.67%,均无显著差异。

局限性

  • 研究样本量小。
  • 缺乏累积结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does artificial oocyte activation improve clinical outcomes for patients at risk of intracytoplasmic sperm injection (ICSI) fertilization failure? DESIGN: In this study, sibling oocytes from patients with previous ICSI failure or severe teratozoospermia were divided equally into two groups, half for artificial oocyte activation (AOA) with ionomycin after conventional ICSI and the other half for conventional ICSI only (non-AOA). The fertilization rates, cleavage rates, transferable embryo rates and blastulation rates of the two groups were compared first; the clinical pregnancy and live birth rates were also compared to assess the efficiency and safety of AOA. RESULT: The outcomes of the AOA group were significantly better than those of the conventional ICSI group in terms of the fertilization (50.38% versus 33.86%, respectively, P < 0.001), cleavage (59.16% versus 39.04%, respectively, P < 0.001) and transferable embryo rates (43.51% versus 26.69%, respectively, P < 0.001). The blastulation (43.53% versus 36.11%, respectively), implantation (26.83% versus 15.79%, respectively), clinical pregnancy (38.46% versus 25%, respectively) and live birth rates (38.46% versus 16.67%, respectively) were not significantly different. CONCLUSION: This study showed that AOA improved some aspects of cycles at risk of ICSI failure by increasing the fertilization and transferable embryo rates. But blastulation, pregnancy and implantation rates were not improved. The study is limited by its small size and absence of data on cumulative outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Li J, Zheng X, Lian Y, et al. Artificial oocyte activation improves cycles with prospects of ICSI fertilization failure: a sibling oocyte control study. Reprod Biomed Online. 2019. PMID: 31160240. doi:10.1016/j.rbmo.2019.03.216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。